Loading clinical trials...
Loading clinical trials...
This randomized phase III trial will compare the outcomes of three treatment modalities for early-stage glottic laryngeal cancer (T1-T2N0): transoral CO₂ laser microsurgery (TLM), volumetric modulated...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Viktoras Rudzianskas
NCT05688488 · Glottic Web of Larynx, Laryngeal Stenosis, and more
NCT00576134 · Swallowing Disorders, Dysphagia, and more
NCT05406024 · Esophageal Neoplasm, Laryngeal Neoplasms
NCT03548285 · Glottic Carcinoma
NCT04995120 · Laryngeal Cancer, Hypopharynx Cancer, and more
Lithuanian University of Health Sciences Kaunas Clinics
Kaunas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions